Research
What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.
359 Articles
Targeting AXL May Improve Chemotherapy for Pancreatic Cancer
Dr. Shaalan Beg describes a clinical trial using the kinase inhibitor bemcentinib along with chemotherapy as a way to slow down or stop pancreatic cancer.
New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients
Genetics impact your treatment for pancreatic cancer. Dr. Sapna Syngal discusses the recommendation of genetic testing for all pancreatic cancer patients.
Immunotherapy Combination Plus Radiation for Pancreatic Cancer
Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
Which Is the Best Screening Method for Pancreatic Cancer?
Dr. Aimee Lucas outlines the pros and cons of various screening methods that can be used for pancreatic cancer, and who should be using them.
Personalized Immunotherapy Vaccine for Pancreatic Cancer
Researchers are creating a personalized vaccine to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.
Radiotherapy Implant plus Standard Chemotherapy
The OncoSil radiotherapy implant device is being tested on pancreatic cancer in a clinical trial that combines it with standard chemotherapy.
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.
A New Combination Chemotherapy Before Surgery
A new clinical trial adds vitamin D to standard of care chemotherapy before surgery, to make pancreatic cancer tumors more removable.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.